Copied
 
 
Formål
Formål
Selskabets formål er produktion, køb, salg og marketing af diagnostikudstyr og hermed beslægtede produkter samt anden i forbindelse med disse formål stående virksomhed. Selskabets formål er herudover at eje kapitalandele i andre selskaber.
Sidst opdateret den 09.02.2015 og angivet som gældende fra 29.04.2014 (3654 dage).
Ingen historik.
Status
Virksomhedsstatus
NORMAL.
Sidst opdateret den 09.02.2015 og angivet som gældende fra 19.01.2001 (8502 dage).
Ingen historik.
Branche
Branche
Engroshandel med læge- og hospitalsartikler (464620).
Sidst opdateret den 08.02.2008 og angivet som gældende fra 01.01.2008 (5964 dage).
HistorikStartStop
Engroshandel med læge- og hospitalsartikler (464620)01.01.2008
Fremstilling af elektrodiagnostiske apparater (331030)01.07.200131.12.2007
Engroshandel med kontormaskiner, edb-maskiner og -udstyr (516410)29.06.200130.06.2001
Uoplyst (980000)19.01.200128.06.2001
Revision
Revisionfravalgt
false.
Sidst opdateret den 11.03.2015 og angivet som gældende fra 19.01.2001 (8502 dage).
Ingen historik.
Revisor
Revisor
EY Godkendt Revisionspartnerselskab
Sidst opdateret den 09.02.2015 og angivet som gældende fra 10.10.2014 (3490 dage).
HistorikStartStop
EY Godkendt Revisionspartnerselskab10.10.2014
ERNST & YOUNG DENMARK P/S15.05.201210.10.2014
John Hauschildt Ladekarl.12.06.200115.05.2012
PricewaterhouseCoopers, Statsautoriseret Revisionsinteressentskab19.01.200112.06.2001
Form
Virksomhedsform
80.
Sidst opdateret den 26.01.2001 og angivet som gældende fra 19.01.2001 (8502 dage).
Ingen historik.
Kontakt
Ingen nuværende registrering.
Ingen historik.
Telefon
HistorikStartStop
3363838323.08.200107.02.2002
Virksomheden har ikke ændret Telefon i sin levetid.
Ingen nuværende registrering.
Navne
Tegningsregel
Tegningsregel
Selskabet tegnes af to medlemmer af bestyrelsen i forening eller af en direktør.
Sidst opdateret den 09.02.2015 og angivet som gældende fra 29.04.2014 (3654 dage).
Fortolkning (2 tegningsmuligheder)
2 bestyrelsesmedlemmer +
1 direktør
Ingen historik.
Ansatte
30.04.2024
Kapital
30.04.2024
Fra årsrapport
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:EY Godkendt Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:30700228
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):Basis for opinion We conducted our audit in accordance with International Standards on Auditing (ISAs) and additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the financial statements" section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Independence We are independent of the Company in accordance with the International Ethics Standards Board for Accountants' International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code.
Konklusion (revision):Opinion We have audited the financial statements of BIOMERIEUX DENMARK ApS for the financial year 1 January - 31 December 2022, which comprise income statement, balance sheet, statement of changes in equity and notes, including accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2022 and of the results of the Company's operations for the financial year 1 January - 31 December 2022 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision): Management is responsible for the Management's review. Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of the Management's review. , Statement on the Management's review Management is responsible for the Management's review. Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of the Management's review.
Bibranche
Ingen nuværende registrering.
Ingen historik.
Børsnoteret
30.04.2024
Ingen nuværende registrering.
Ingen historik.
Hjemmeside
30.04.2024
Ingen nuværende registrering.
Ingen historik.